K. Dheda (Cape Town, South Africa), S. Borisov (Moscow, Russian Federation)
First countrywide observational study of acquired drug resistance among TB cases in Ukraine
A. Dudnyk (Vinnytsia, Ukraine), Y. Haborets (Vinnytsia, Ukraine), V. Kapitula (Vinnytsia, Ukraine), L. Kulyk (Vinnytsia, Ukraine), J. Dominguez (Badalona, Spain)
|   |
Video observed treatment for TB patients. Belarus experience.
A. Skrahina (Minsk, Belarus), H. Hurevich (Minsk, Belarus), E. Ilyasova (Minsk, Belarus), V. Akulov (Minsk, Belarus), D. Klimuk (Minsk, Belarus), V. Grankov (Minsk, Belarus), A. Skrahin (Minsk, Belarus), M. Dara (Copenhagen, Denmark)
| |
Treatment of multidrug-resistant tuberculosis (MDR-TB) with modified shorter all-oral treatment regimen (mSTR) under operational research conditions in Belarus
A. Skrahina (Minsk, Belarus), N. Yatskevich (Minsk, Belarus), H. Hurevich (Minsk, Belarus), V. Grankov (Minsk, Belarus), D. Klimuk (Minsk, Belarus), V. Solodovnikova (Minsk, Belarus), D. Viatushka (Minsk, Belarus), A. Skrahin (MInsk, Belarus), E. Gurbanova (Tartu, Estonia), M. Dara (Copenhagen, Denmark)
| |
Line Probe Assay as a preliminary investigation for diagnosing resistant tuberculosis : A Single center experience
D. Muthreja (Nagpur (Maharashtra), India), R. Swarnakar (Nagpur (Maharashtra), India), A. Sontakke (Nagpur (Maharashtra), India)
| |
Incidence of cycloserine induced neurotoxicity in drug resistant TB patients attending a tertiary care hospital.
P. Singhal (Mumbai, India), P. Lunia (Mumbai, India), K. Salgia (Mumbai, India), I. Syed (Mumbai, India)
| |
Adverse effects among MDR/XDR TB patients with viral hepatitus appearing during TB chemotherapy
E. Vaniev (Moscow, Russian Federation), A. Samoilova (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation), O. Lovacheva (Moscow, Russian Federation), T. Tyulkova (Moscow, Russian Federation)
| |
Proteasome Accessory Factor-C (PafC) as a potential regulator of mycobacterial survival in multi drug-resistant tuberculosis patients
A. NARAIN (Lucknow (Uttar Pradesh), India), R. Dubey (Lucknow (Uttar Pradesh), India), A. Verma (Lucknow (Uttar Pradesh), India), A. Srivastava (Lucknow (Uttar Pradesh), India), S. Kant (Lucknow (Uttar Pradesh), India)
| |
Induction of M. tuberculosis (MTB) drug resistance (DR) mutations in HIV-infected hosts and pathways of further spread of the evolutionary successful drug-resistant MTB clonal lines
G. Kaminskiy (Moscow, Russian Federation), A. Panova (Moscow, Russian Federation), E. Karamov (Moscow, Russian Federation), E. Veselova (Moscow, Russian Federation), S. Smerdin (Moscow, Russian Federation), M. Leichliyader (Chelyabinsk, Russian Federation), A. Samoilova (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation)
| |
Multivariate analysis of the effectiveness of bedaquiline-containing chemotherapy regimens in previously treated XDR TB patients
N. Stavitskaya (Novosibirsk, Russian Federation), S. Smerdin (Moscow, Russian Federation), D. Kudlay (Moscow, Russian Federation), N. Doktorova (Moscow, Russian Federation), O. Tlif (Moscow, Russian Federation), T. Petrenko (Novosibirsk, Russian Federation), T. Kolpakova (Novosibirsk, Russian Federation)
| |
The effect of anti-tuberculosis chemotherapy using second-line drugs on the structural and functional state of the thyroid gland
a. polyakova (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation)
| |
Predictors of death in patients with MDR-TB and HIV
L. Rusakova (Moscow, Russian Federation), S. Saenko (Moscow, Russian Federation), S. Sterlikov (Moscow, Russian Federation)
| |
Frequency of side effects among patients with drug resistant tuberculosis (DR-TB) by resistance pattern in a high burden country.
K. MALU (MUMBAI, India), J. Tornheim (BALTIMORE, United States of America), A. Gupta (BALTIMORE, United States of America), K. Girija (MUMBAI, India), Z. Udwadia (MUMBAI, India)
| |
Rapid Molecular Diagnosis Of Multidrug-Resistant Tuberculosis in South Eastern Region of Romania
I. Arghir (Constanta (Constanta), Romania), S. Cambrea (Constanta (Constanta), Romania), E. Dantes (Constanta (Constanta), Romania), V. Cojocaru (Constanta (Constanta), Romania), I. Ion (Constanta (Constanta), Romania)
| |
Tuberculosis in Estonia: a major impact of Russian MDR Mycobacterium tuberculosis Beijing B0/W148-cluster
A. Gerasimova (St. Petersburg, Russian Federation), A. Vyazovaya (St. Petersburg, Russian Federation), K. Levina (Tallinn, Estonia), M. Kütt (Tallinn, Estonia), I. Mokrousov (St. Petersburg, Russian Federation)
| |
Safety of the endobronchial valve use in the complex treatment of patients with destructive MDR/XDR TB associated with HIV infection.
S. Sklyuev (Novosibirsk, Russian Federation), D. Krasnov (Novosibirsk, Russian Federation), Y. Petrova (Novosibirsk, Russian Federation), E. Myshkova (Novosibirsk, Russian Federation)
| |
CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
S. Patil (Latur (Maharashtra), India), G. Narwade (Latur (Maharashtra), India), G. Gondhali (Latur (Maharashtra), India)
| |
Application of next-generation sequencing to detect MTB resistance to first- and second-line anti-TB drugs
A. Panova (Moscow, Russian Federation), A. Vinokurov (Moscow, Russian Federation), D. Lagutkin (Moscow, Russian Federation), A. Gracheva (Moscow, Russian Federation), A. Nikolaev (Moscow, Russian Federation), A. Samoilova (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation)
| |
Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts.
K. Glebov (Moscow, Russian Federation), A. Russkikh (Moscow, Russian Federation), A. Samoilova (Moscow, Russian Federation), O. Lovacheva (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation), Y. Timakova (Moscow, Russian Federation)
| |